Tuesday, January 11, 2022

23andMe got the green light to test for prostate cancer risk

23andMe got the green light to test for prostate cancer risk

Why it matters: Genetics testing company 23andMe has added a third kind of cancer testing to its offerings. Remember when people thought genetics testing companies might stick to just helping you deduce your ancestry?

Full Story: The Verge (1/10) 

LinkedIn Twitter Facebook Email

No comments:

Post a Comment